European Medical Solutions (ALEMS.BR)

EUR 4.9

(1.07%)

Revenue Summary of European Medical Solutions

European Medical Solutions's latest annual revenue in 2023 was 40.56 Million EUR , up 14.76% from previous year.
European Medical Solutions's latest quarterly revenue in 2023 FY was 42.52 Million EUR , up 14.76% from previous quarter.
European Medical Solutions reported a annual revenue of 37.05 Million EUR in annual revenue 2022, down -2.53% from previous year.
European Medical Solutions reported a annual revenue of 38.01 Million EUR in annual revenue 2021, up 10491.9% from previous year.
European Medical Solutions reported a quarterly revenue of 42.52 Million EUR for 2023 FY, up 14.76% from previous quarter.
European Medical Solutions reported a quarterly revenue of 20.72 Million EUR for 2023 Q4, down -4.9% from previous quarter.

Annual Revenue Chart of European Medical Solutions (2023 - 2013)

Historical Annual Revenue of European Medical Solutions (2023 - 2013)

Year	Revenue	Revenue Growth
2023	40.56 Million EUR	14.76%
2022	37.05 Million EUR	-2.53%
2021	38.01 Million EUR	10491.9%
2020	358.94 Thousand EUR	-66.29%
2019	1.06 Million EUR	86.57%
2018	570.75 Thousand EUR	-5.5%
2017	604 Thousand EUR	-64.12%
2016	1.68 Million EUR	41978.93%
2015	4000.00 EUR	-20.0%
2014	5000.00 EUR	-28.57%
2013	7000.00 EUR	0.0%

Year	Revenue	Revenue Growth
2023 Q2	21.79 Million EUR	20.67%
2023 FY	42.52 Million EUR	14.76%
2023 Q4	20.72 Million EUR	-4.9%
2022 Q4	18.06 Million EUR	-4.89%
2022 FY	37.05 Million EUR	-2.53%
2022 Q2	18.99 Million EUR	4576285.54%
2021 FY	38.01 Million EUR	10491.9%
2021 Q4	415.00 EUR	0.0%
2021 Q2	- EUR	-100.0%
2020 Q2	16 Thousand EUR	-92.23%
2020 FY	358.94 Thousand EUR	-66.29%
2020 Q4	342.94 Thousand EUR	2043.4%
2019 Q4	205.84 Thousand EUR	-76.04%
2019 FY	1.06 Million EUR	86.57%
2019 Q2	859 Thousand EUR	362.45%
2018 Q4	185.75 Thousand EUR	-51.75%
2018 FY	570.75 Thousand EUR	-5.5%
2018 Q2	385 Thousand EUR	26.64%
2017 Q2	300 Thousand EUR	-78.33%
2017 Q4	304 Thousand EUR	1.33%
2017 FY	604 Thousand EUR	-64.12%
2016 Q2	298 Thousand EUR	29700.0%
2016 FY	1.68 Million EUR	41978.93%
2016 Q4	1.38 Million EUR	364.61%
2015 Q2	3000.00 EUR	0.0%
2015 Q4	1000.00 EUR	-66.67%
2015 FY	4000.00 EUR	-20.0%
2014 FY	5000.00 EUR	-28.57%
2013 FY	7000.00 EUR	0.0%

Peer Revenue Comparison of European Medical Solutions

Name	Revenue	Revenue Difference
Nicox S.A.	257 Thousand EUR	-15683.658%
FERMENTALG	4.05 Million EUR	-899.852%
argenx SE	1.13 Billion EUR	96.424%
BioSenic S.A.	543 Thousand EUR	-7370.35%
Celyad Oncology SA	102 Thousand EUR	-39668.627%
Hyloris Pharmaceuticals SA	2.08 Million EUR	-1843.651%
Onward Medical N.V.	532 Thousand EUR	-7524.812%
Oxurion NV	263 Thousand EUR	-15323.574%
PHAXIAM Therapeutics S.A.	1.32 Million EUR	-2959.125%
Financière de Tubize SA	- EUR	-Infinity%
UCB SA	5.25 Billion EUR	99.228%